Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Hemostasis Tests Market Report Overview
The hemostasis tests market size was valued at $594.3 million in 2023 and will grow at a CAGR of more than 1% during 2023-2033. There is a strong desire among physicians for accurate and reliable POC testing of D-Dimer testing in emergencies such as VTE, which will drive market growth during the forecast period.
Hemostasis Tests Market Outlook 2023-2023 ($ Billion)
Buy Full Report for More Insights on the Hemostasis Tests Market Forecast
The hemostasis tests market research report identifies quantitative market trends within In-vitro Diagnostic devices therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also provides an in-depth discussion of COVID-19’s effects on the hemostasis tests market for 2020 and beyond. Furthermore, the report provides hemostasis tests for market share by a company that will help in identifying untapped market opportunities.
Market Size (2023) | $594.3 billion |
CAGR (2023-2033) | >1% |
Historic Period | 2015-2022 |
Forecast Period | 2023-2033 |
Key Segments | · Activated Partial Thromboplastin Time Laboratory Tests
· Activated Partial Thromboplastin Time Point of Care (POC) Tests · D-Dimer Laboratory Tests · D-Dimer Point of Care (POC) Tests · Prothrombin Time Point of Care (POC) Tests |
Key Regions | · Asia-Pacific
· Europe · Middle East and Africa · North America · South and Central America |
Key Companies | · Abbott Laboratories
· F. Hoffmann-La Roche Ltd · Siemens Healthineers AG · Diagnostica Stago SAS · Werfen Life SA |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Hemostasis Tests Market Segments
A few of the key segments of hemostasis tests are activated partial thromboplastin time laboratory tests, activated partial thromboplastin time point of care (POC) tests, d-dimer laboratory tests, d-dimer point of care (POC) tests, and prothrombin time point of care (POC) tests.
In 2023, the POC tests segment accounted for the highest market share. Prothrombin POC tests are performed on POC PT/INR analyzers. These analyzers are handheld devices that are lightweight, convenient, and easy to use. They do not require an invasive venous blood draw and provide instant results.
Hemostasis Tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Insights on the Segments in the Hemostasis Tests Market
Hemostasis Tests Market Segmentation by Regions
The key regions in the hemostasis tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, the North American hemostasis test market share was the highest. In the US, Canada, and Mexico prothrombin (PT) tests are preferred hemostasis tests to monitor oral anticoagulants (Vitamin-K antagonists) such as warfarin, phenprocoumon, and acenocoumarol. These tests also help to identify coagulation abnormalities in the perioperative period.
Hemostasis Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Insights on the Regions in the Hemostasis Tests Market
Hemostasis Tests Market – Competitive Landscape
In 2023, the F. Hoffmann-La Roche Ltd hemostasis tests market share was the highest
The key companies in the Hemostasis Tests market are:
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Diagnostica Stago SAS
- Werfen Life SA
Hemostasis Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Insights on the Companies in the Hemostasis Tests Market
Hemostasis Tests Market Dynamics
Trends: The increasing prevalence of surgical cases is one of the factors driving the growth of the hemostasis testing market. There is demand for POC tests for hemostasis tests because of the time-consuming process of laboratory-based tests that can lead to treatment delays. These diagnostic tests provide rapid results, reduce hospital stays, and lead to immediate treatment decisions.
Future Outlook: The prevalence of surgical cases is increasing in many countries and geographical regions, which will lead to higher numbers of prothrombin (PT) tests and activated partial thromboplastin Time (aPTT) tests being utilized. Moreover, the incidence of venous thromboembolism (VTE) is also increasing worldwide, which will drive sales of D-Dimer tests during the forecast period.
Buy the Full Report for More Insights on the Hemostasis Tests Market Dynamics
Segments Covered in this Report
Hemostasis Tests Segment Outlook ($ Billion, 2015-2033)
- Activated Partial Thromboplastin Time Laboratory Tests
- Activated Partial Thromboplastin Time Point of Care (POC) Tests
- D-Dimer Laboratory Tests
- D-Dimer Point of Care (POC) Tests
- Prothrombin Time Point of Care (POC) Tests
Hemostasis Tests Regional Outlook ($ Billion, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
The hemostasis tests market research report includes an insightful review of the key industry trends.
- The hemostasis tests market report offers annualized market revenue details by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, country, and global hemostasis tests market insights:
- The hemostasis tests market share report offers qualitative insights into global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- Hemostasis tests market SWOT analysis.
- The report provides trends and hemostasis tests market competitive dynamics.
Buy the Full Report for More Insights on the Companies in the Hemostasis Tests Market
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources, including databases of government procedures and hospital purchasing.
Companies covered: Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Diagnostica Stago SAS, Werfen Life SA, Bio-Rad Laboratories Inc, bioMerieux SA, Quidelortho Corp, Danaher Corp, Revvity Inc, and others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
- Extensive coverage of the hemostasis tests market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the hemostasis tests market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the COVID-19 impact on the hemostasis tests market.
- Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Hemostasis Tests market.
- Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of hemostasis tests market share by company. Identify strong competitors and create winning strategies to stand out in the global Hemostasis Tests market.
- Track regional hemostasis tests market sales as well as country-specific transactions from 2015-2033.
- Organize your sales and marketing efforts by identifying the global hemostasis tests market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Diagnostica Stago SAS
Werfen Life SA
Bio-Rad Laboratories Inc
bioMerieux SA
Quidelortho Corp
Danaher Corp
Revvity Inc
Others
Frequently asked questions
-
What was the hemostasis tests market size in 2023?
The hemostasis tests market size was $594.3 million in 2023.
-
What will the hemostasis tests market growth rate be during the forecast period?
The hemostasis tests market is expected to grow at a CAGR of more than 1% during 2023-2033.
-
Which was the leading segment in the hemostasis tests market in 2023?
In 2023, the prothrombin time point of care (POC) tests segment accounted for the highest market share.
-
Which region dominated the hemostasis tests market in 2023?
In 2023, the North American hemostasis tests market share was the highest.
-
Which are the key companies operating in the hemostasis tests market?
The key companies in the hemostasis tests market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Diagnostica Stago SAS, and Werfen Life SA among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.